Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2020-05-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a new veterinary drug registration certificate from the Ministry of Agriculture and Rural Affairs. It details the product information, development background, market context, and significance to the company. The document is short (1508 characters) and serves as a formal announcement of a regulatory approval rather than a financial report or detailed operational disclosure. It does not contain financial statements, management discussion, or other report elements. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-05-20 Chinese
2019年年度股东大会的法律意见
Regulatory Filings Classification · 95% confidence The document contains only references to omitted pictures and has a very short length (384 characters). There is no textual content indicating any report, announcement, or detailed information. Given the lack of substantive content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2020-05-19 Chinese
2019年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2019 Annual General Meeting Resolution Announcement" for 普莱柯生物工程股份有限公司. It details the resolutions passed at the 2019 Annual General Meeting (AGM) held on May 19, 2020, including voting results on various agenda items such as the 2019 annual report, board reports, financial statements, profit distribution, and other corporate matters. The document includes attendance details, voting percentages, and legal witness statements confirming the validity of the meeting and resolutions. This is a formal announcement of the voting results and resolutions passed at the AGM, not the full annual report or financial statements themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3573 characters, which is consistent with an announcement rather than a full report. Confidence is high due to clear meeting and voting details and the nature of the content.
2020-05-19 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a new veterinary drug registration certificate from the Ministry of Agriculture and Rural Affairs. It details the product information, development background, market context, and regulatory procedures. The document is an official announcement of a regulatory approval event, not a financial report, management change, or other filing types. It does not contain financial statements or detailed financial data. The document length is short (1493 characters), and it serves as a formal public notice of a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-15 Chinese
2019年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2019 Annual General Meeting (AGM) of 普莱柯生物工程股份有限公司, dated May 2020. It includes detailed meeting instructions, agenda, and multiple proposals for shareholder approval, such as the 2019 annual report, board work report, supervisory board report, independent directors' report, financial results, profit distribution, appointment of auditors, and other governance matters. The content is typical of AGM meeting materials, including voting procedures and detailed reports to be discussed and approved at the AGM. There is no indication that this is the annual report itself, but rather the meeting materials for the AGM where the annual report and other reports are presented and voted on. The document length is substantial (15,000 characters), consistent with detailed AGM materials. Therefore, the document fits the category of AGM Information (AGM-R).
2020-05-11 Chinese
关于股份回购进展情况的公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from a company regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with relevant regulations. The document does not contain financial statements or detailed financial analysis but focuses on the status update of the share buyback activity. According to the filing definitions, this fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document length and content confirm it is not a full financial report or an announcement of a report publication but a direct update on share repurchase progress.
2020-05-08 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.